Mechanisms of actions(s) of simvastatin in uterine leiomyoma
- Funded by National Institutes of Health (NIH)
- Total publications:2 publications
Grant number: 3R01HD094380-04S1
Grant search
Key facts
Disease
COVID-19Start & end year
20182023Known Financial Commitments (USD)
$300,000Funder
National Institutes of Health (NIH)Principal Investigator
Mostafa BorahayResearch Location
United States of AmericaLead Research Institution
N/AResearch Priority Alignment
N/A
Research Category
Vaccines research, development and implementation
Research Subcategory
Adverse events associated with immunization
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Unspecified
Broad Policy Alignment
Pending
Age Group
Adults (18 and older)
Vulnerable Population
Women
Occupations of Interest
Unspecified
Abstract
PROJECT SUMMARY Regular menstruation is considered an indicator of whole-body health, and subtle changes in health can lead to noticeable fluctuations in the regular cycle. The large roll-out of COVID-19 vaccine was accompanied by anecdotal evidence that suggested that those who menstruate experienced changes in the menstrual cycle with some reporting unexpected spotting or heavier and/or longer cycles. Unfortunately, the initial clinical trials for the Pfizer, Moderna, and Johnson and Johnson vaccines did not follow up on possible menstrual cycle changes. The first aim of our project is to assess the clinical effects of the COVID-19 vaccination on the menstrual cycle using data from participants in our ongoing clinical trial who document their menstrual cycle using a menstrual diary. We will expand recruitment through a national, digital campaign: www.covidmenses.org. Data reported in the popular Period-Tracking App "Clue" will also be used to assess the clinical effects. The second aim will focus on the mechanisms of COVID-19 vaccines' effects on the menstrual cycle through assessing endometrial changes associated with vaccination. This will be done by comparing the immune cell profile at the level of the endometrium before and after vaccination as well as evaluating the expression of cytokines, chemokines and extracellular degradation mediators. The successful completion of this project will provide evidence on the effect of COVID-19 vaccination on menstrual health. This can reduce vaccine anxiety and hesitancy among those who menstruate.
Publicationslinked via Europe PMC
Last Updated:an hour ago
View all publications at Europe PMC